10.14.2024 - Jason Efstathiou - PARTIQoL - ASTRO 2024

Check out the latest QuadCast where we interview Jason Efstathiou at the 2024 ASTRO Annual Meeting about his Plenary Session on the PARTIQoL trial, which is a first of its kind randomized trial of IMRT vs. Proton Therapy for localized prostate cancer. Don't miss it.

Om Podcasten

With increasing information overload and packed work schedules, staying up-to-date on the newest oncologic advances is harder than ever. But take heart! The QuadShot is freshly brewed four mornings each week so you can quickly down and digest the day's most pertinent cancer news.